(FROG) Jfrog - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: IL0011684185
Stock: Repository, Curation, Security, Distribution, ML
Total Rating 58
Risk 51
Buy Signal -1.01
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 52.7% |
| Relative Tail Risk | -13.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.71 |
| Alpha | 13.43 |
| Character TTM | |
|---|---|
| Beta | 1.268 |
| Beta Downside | 1.271 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.19% |
| CAGR/Max DD | 0.54 |
Description: FROG Jfrog January 08, 2026
JFrog Ltd. (NASDAQ:FROG) operates a unified software supply-chain platform that spans artifact storage (Artifactory), security scanning (Xray, Advanced Security, Runtime Security), distribution, and emerging MLOps capabilities (JFrog ML). Its product suite is sold via tiered subscriptions-Pro, Pro X, Enterprise X, and Enterprise Plus-targeting technology, financial services, retail, healthcare, and telecom firms across the U.S., Israel, India, and other global markets.
Key recent metrics (Q3 2024) show annual recurring revenue (ARR) of roughly **$1.1 bn**, a **+27 % YoY growth** driven by strong uptake of the Enterprise Plus tier and expanding MLOps usage. Gross margins have stabilized near **78 %**, while subscription churn remains low at **~4 %** annually, reflecting sticky enterprise contracts. The broader DevSecOps market is expanding at a **~15 % CAGR**, fueled by heightened regulatory scrutiny on software supply-chain security and accelerated cloud migration-both macro-drivers that support JFrog’s growth narrative.
For a deeper, data-driven assessment of JFrog’s valuation and risk profile, you might explore the detailed analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -79.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 2.69 > 1.0 |
| NWC/Revenue: 86.06% < 20% (prev 73.51%; Δ 12.55% < -1%) |
| CFO/TA 0.11 > 3% & CFO 144.2m > Net Income -79.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (117.3m) vs 12m ago 7.66% < -2% |
| Gross Margin: 75.66% > 18% (prev 0.78%; Δ 7489 % > 0.5%) |
| Asset Turnover: 42.84% > 50% (prev 37.90%; Δ 4.94% > 0%) |
| Interest Coverage Ratio: -13.28 > 6 (EBITDA TTM -51.4m / Interest Expense TTM -5.81m) |
Altman Z'' -0.33
| A: 0.34 (Total Current Assets 800.2m - Total Current Liabilities 367.6m) / Total Assets 1.27b |
| B: -0.33 (Retained Earnings -416.3m / Total Assets 1.27b) |
| C: -0.07 (EBIT TTM -77.2m / Avg Total Assets 1.17b) |
| D: -1.01 (Book Value of Equity -410.4m / Total Liabilities 406.1m) |
| Altman-Z'' Score: -0.33 = B |
Beneish M -3.20
| DSRI: 0.92 (Receivables 104.4m/92.9m, Revenue 502.6m/409.7m) |
| GMI: 1.03 (GM 75.66% / 77.59%) |
| AQI: 0.82 (AQ_t 0.35 / AQ_t-1 0.43) |
| SGI: 1.23 (Revenue 502.6m / 409.7m) |
| TATA: -0.18 (NI -79.8m - CFO 144.2m) / TA 1.27b) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of FROG shares?
As of February 07, 2026, the stock is trading at USD 47.99 with a total of 3,499,767 shares traded.
Over the past week, the price has changed by -12.43%, over one month by -18.91%, over three months by +1.54% and over the past year by +33.16%.
Over the past week, the price has changed by -12.43%, over one month by -18.91%, over three months by +1.54% and over the past year by +33.16%.
Is FROG a buy, sell or hold?
Jfrog has received a consensus analysts rating of 4.45.
Therefore, it is recommended to buy FROG.
- StrongBuy: 12
- Buy: 5
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FROG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 72 | 50% |
| Analysts Target Price | 72 | 50% |
| ValueRay Target Price | 53.8 | 12.1% |
FROG Fundamental Data Overview January 31, 2026
P/E Forward = 66.2252
P/S = 13.048
P/B = 8.2806
Revenue TTM = 502.6m USD
EBIT TTM = -77.2m USD
EBITDA TTM = -51.4m USD
Long Term Debt = 11.1m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 7.06m USD (from shortTermDebt, last quarter)
Debt = 11.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -67.2m USD (from netDebt column, last quarter)
Enterprise Value = 5.92b USD (6.56b + Debt 11.1m - CCE 651.1m)
Interest Coverage Ratio = -13.28 (Ebit TTM -77.2m / Interest Expense TTM -5.81m)
EV/FCF = 42.00x (Enterprise Value 5.92b / FCF TTM 140.9m)
FCF Yield = 2.38% (FCF TTM 140.9m / Enterprise Value 5.92b)
FCF Margin = 28.03% (FCF TTM 140.9m / Revenue TTM 502.6m)
Net Margin = -15.88% (Net Income TTM -79.8m / Revenue TTM 502.6m)
Gross Margin = 75.66% ((Revenue TTM 502.6m - Cost of Revenue TTM 122.3m) / Revenue TTM)
Gross Margin QoQ = 77.43% (prev 76.26%)
Tobins Q-Ratio = 4.68 (Enterprise Value 5.92b / Total Assets 1.27b)
Interest Expense / Debt = 35.81% (Interest Expense 3.99m / Debt 11.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -61.0m (EBIT -77.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.18 (Total Current Assets 800.2m / Total Current Liabilities 367.6m)
Debt / Equity = 0.01 (Debt 11.1m / totalStockholderEquity, last quarter 859.4m)
Debt / EBITDA = 1.31 (negative EBITDA) (Net Debt -67.2m / EBITDA -51.4m)
Debt / FCF = -0.48 (Net Debt -67.2m / FCF TTM 140.9m)
Total Stockholder Equity = 814.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -6.80% (Net Income -79.8m / Total Assets 1.27b)
RoE = -9.79% (Net Income TTM -79.8m / Total Stockholder Equity 814.9m)
RoCE = -9.35% (EBIT -77.2m / Capital Employed (Equity 814.9m + L.T.Debt 11.1m))
RoIC = -7.49% (negative operating profit) (NOPAT -61.0m / Invested Capital 814.9m)
WACC = 10.62% (E(6.56b)/V(6.57b) * Re(10.59%) + D(11.1m)/V(6.57b) * Rd(35.81%) * (1-Tc(0.21)))
Discount Rate = 10.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.52%
[DCF Debug] Terminal Value 73.23% ; FCFF base≈121.0m ; Y1≈149.3m ; Y5≈254.3m
Fair Price DCF = 24.19 (EV 2.79b - Net Debt -67.2m = Equity 2.86b / Shares 118.3m; r=10.62% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 86.28 | EPS CAGR: 22.11% | SUE: 2.65 | # QB: 5
Revenue Correlation: 99.73 | Revenue CAGR: 25.03% | SUE: 3.86 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=19
EPS next Year (2026-12-31): EPS=0.88 | Chg30d=+0.004 | Revisions Net=+1 | Growth EPS=+11.6% | Growth Revenue=+16.6%
P/S = 13.048
P/B = 8.2806
Revenue TTM = 502.6m USD
EBIT TTM = -77.2m USD
EBITDA TTM = -51.4m USD
Long Term Debt = 11.1m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 7.06m USD (from shortTermDebt, last quarter)
Debt = 11.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -67.2m USD (from netDebt column, last quarter)
Enterprise Value = 5.92b USD (6.56b + Debt 11.1m - CCE 651.1m)
Interest Coverage Ratio = -13.28 (Ebit TTM -77.2m / Interest Expense TTM -5.81m)
EV/FCF = 42.00x (Enterprise Value 5.92b / FCF TTM 140.9m)
FCF Yield = 2.38% (FCF TTM 140.9m / Enterprise Value 5.92b)
FCF Margin = 28.03% (FCF TTM 140.9m / Revenue TTM 502.6m)
Net Margin = -15.88% (Net Income TTM -79.8m / Revenue TTM 502.6m)
Gross Margin = 75.66% ((Revenue TTM 502.6m - Cost of Revenue TTM 122.3m) / Revenue TTM)
Gross Margin QoQ = 77.43% (prev 76.26%)
Tobins Q-Ratio = 4.68 (Enterprise Value 5.92b / Total Assets 1.27b)
Interest Expense / Debt = 35.81% (Interest Expense 3.99m / Debt 11.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -61.0m (EBIT -77.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.18 (Total Current Assets 800.2m / Total Current Liabilities 367.6m)
Debt / Equity = 0.01 (Debt 11.1m / totalStockholderEquity, last quarter 859.4m)
Debt / EBITDA = 1.31 (negative EBITDA) (Net Debt -67.2m / EBITDA -51.4m)
Debt / FCF = -0.48 (Net Debt -67.2m / FCF TTM 140.9m)
Total Stockholder Equity = 814.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -6.80% (Net Income -79.8m / Total Assets 1.27b)
RoE = -9.79% (Net Income TTM -79.8m / Total Stockholder Equity 814.9m)
RoCE = -9.35% (EBIT -77.2m / Capital Employed (Equity 814.9m + L.T.Debt 11.1m))
RoIC = -7.49% (negative operating profit) (NOPAT -61.0m / Invested Capital 814.9m)
WACC = 10.62% (E(6.56b)/V(6.57b) * Re(10.59%) + D(11.1m)/V(6.57b) * Rd(35.81%) * (1-Tc(0.21)))
Discount Rate = 10.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.52%
[DCF Debug] Terminal Value 73.23% ; FCFF base≈121.0m ; Y1≈149.3m ; Y5≈254.3m
Fair Price DCF = 24.19 (EV 2.79b - Net Debt -67.2m = Equity 2.86b / Shares 118.3m; r=10.62% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 86.28 | EPS CAGR: 22.11% | SUE: 2.65 | # QB: 5
Revenue Correlation: 99.73 | Revenue CAGR: 25.03% | SUE: 3.86 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=19
EPS next Year (2026-12-31): EPS=0.88 | Chg30d=+0.004 | Revisions Net=+1 | Growth EPS=+11.6% | Growth Revenue=+16.6%